13F-HR filed by SymBiosis Capital Partners, LLC
SymBiosis Capital Partners, LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-12, with 6 holding rows worth $52,769,920.
- Accession
- 0002006045-26-000007
- Filer
- CIK 2006045
- Filed
- 2026-05-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 6 entries on the cover page, a total value of $52,769,920 stated on the cover page (in dollars after the unit check, H1), rows summing to $52,769,920 with VALUE read as dollars as filed, 13F file number 028-26251. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 1,280,778 | $29,445,086 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 2,354,000 | $13,064,700 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 750,000 | $5,437,500 | dollars as filed | |
| RANI THERAPEUTICS HLDGS INC | 753018100 | CMN | 3,667,585 | $2,694,941 | dollars as filed | |
| CLENE INC | 185634201 | COM NEW | 431,094 | $2,125,293 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 150,000 | $2,400 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002006045-26-000007 | this filing | 2026-05-12 | acceptance time not in the bulk data set |